The Potential Weight Loss Benefits Of Tirzepatide: A Double-Edged Sword?

J Pak Med Assoc. 2023 Nov;73(11):2318. doi: 10.47391/JPMA.9519.
No abstract available

MeSH terms

  • Diabetes Mellitus, Type 2*
  • Gastric Inhibitory Polypeptide*
  • Humans
  • Hypoglycemic Agents

Substances

  • tirzepatide
  • Gastric Inhibitory Polypeptide
  • Hypoglycemic Agents